BRAWN

Brawn Biotech Ltd.

BSE: 530207

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

24.50-0.1 (-0.41%)

5 Oct, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

7.35

P/E (TTM)

7.81

P/B

1.69

P/S (TTM)

0.43

EV/EBITDA

CAPE (5Y)

ROE (TTM)

24.43

ROCE (TTM)

-11.64

ROA (TTM)

4.55

Avg 3Y ROE

-12.93

Earnings 3Y CAGR

Sales 3Y CAGR

-12.90

Sales 5Y CAGR

Debt/Equity

0.00

Consensus TP

Strong Buy %

Promoter Holding

52.94

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Brawn Biotech Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 7.81 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -75.16%

What is P/E Ratio?

Median: 31.44

Value 7.81

-0.84721.21

High and improving ROE

The company reported strong ROE of 24.43% for 12-month ended 30 Jun 2026 and ROE improved by 6573 bps from 1 year ago

What is ROE (FY)?

Moderate revenue growth and above median growth of industry

The company delivered moderate revenue growth of 13.56% for 12-month ended 30 Jun 2026 and the growth was 2.88 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 10.68

Value 13.56

-99.6111701.8

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.0 as on 30 Jun 2026 and Debt to Equity remained same in the last 1 year

What is Debt to Equity?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Low operating margin but improving trend

The company reported low operating margin of -2.64% for 12-month ended 30 Jun 2026 but operating margin improved by 534 bps from 1 year ago

What is Operating profit margin?

Financial Snapshot

See detailed analysis

Multi-year trends for Brawn Biotech Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Brawn Biotech Ltd. Shareholding Pattern

Quarterly breakdown of Brawn Biotech Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	53.71	53.71	53.71	53.71	53.71	53.71	53.71	53.71	53.71	53.73	53.73	53.72	53.72	53.72	53.72	53.72	53.64	53.64	53.64	53.64	53.66	53.66	53.66	53.39	52.94	52.94
Indian Promoter	53.71	53.71	53.71	53.71	53.71	53.71	53.71	53.71	53.71	53.73	53.73	53.72	53.72	53.72	53.72	53.72	53.64	53.64	53.64	53.64	53.66	53.66	53.66	53.39	52.94	52.94
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.35	0.35	0.35	0.35	0.35	0.35	0.35	0.35	0.35	0.35
Mutual Funds / UTI	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.59	0.35	0.35	0.35	0.35	0.35	0.35	0.35	0.35	0.35	0.35
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	45.69	45.69	45.69	45.69	45.69	45.69	45.69	45.69	45.69	45.68	45.68	45.69	45.69	45.69	45.69	45.69	46.01	46.01	46.01	46.01	45.99	45.99	45.99	46.26	46.71	46.71
Bodies Corporate	0.46	0.46	0.47	0.47	0.47	0.47	0.47	0.46	0.58	0.58	0.58	0.58	0.57	0.57	0.57	0.57	0.42	0.42	0.38	0.38	0.38	0.38	0.38	0.38	0.28	0.28
Others (incl. Retail) No. of shareholders	45.23 6,018	45.23 6,021	45.22 6,025	45.22 5,990	45.22 5,937	45.22 5,907	45.22 5,944	45.23 6,030	45.11 6,235	45.10 6,231	45.10 6,228	45.11 6,222	45.12 6,170	45.12 6,194	45.12 6,142	45.12 6,087	45.59 4,118	45.59 4,048	45.63 4,115	45.63 4,018	45.61 3,982	45.61 3,932	45.61 3,915	45.88 3,405	46.43 3,266	46.43 3,247

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Brawn Biotech Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Naimabbas Anvarali Jamani	20 Dec 2024	buy	₹ 22.76	17.65 k	₹ 4.02 lac
Naimabbas Anvarali Jamani	20 Dec 2024	sell	₹ 22.50	2.00 k	₹ 45.00 k

Corporate Actions

History of Brawn Biotech Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 1/share
Record date: 14th Sep 2018Ex-date: 12th Sep 2018
Announced on: 29th May 2018
Dividend₹ 1.50/share
Record date: 15th Sep 2017Ex-date: 14th Sep 2017
Announced on: 29th May 2017

Company Profile

Overview of Brawn Biotech Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Brawn Biotech Limited is an India-based integrated healthcare company. The Companys pharmaceutical products cover all product segments, such as Antibacterials, Cardiovasculars, Antidiabetics, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Antiasthmatics, Antacids, Antimalarial...

Key personnel

Ms. Priyanka Sharma

Compliance Officer, Company Secretary

Mr. Amit Kumar

Manager

Mr. Mayank JainD